Hair Transplantation in Cicatricial Alopecia
EVALUATION OF THE EFFICACY OF FOLLICULAR UNIT EXTRACTION VERSUS FOLLICULAR UNIT EXTRACTION WITH PLATELETS RICH PLASMA IN TREATMENT OF CICATRICAL ALOPECIA
1 other identifier
interventional
20
1 country
1
Brief Summary
follicular unit extraction as a method of hair transplantation in cicatricial alopecia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2020
CompletedFirst Submitted
Initial submission to the registry
July 12, 2020
CompletedFirst Posted
Study publicly available on registry
July 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2020
CompletedJuly 29, 2021
July 1, 2021
11 months
July 12, 2020
July 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
hair regrowth
transplanted hair develop int new hair growth in bald area
6 months
Study Arms (2)
follicular unit extraction
EXPERIMENTALextraction of hair follicle unit from donar area and tranplant it into recepient bald area
foolicular unit extraction and platelet rich plasma
EXPERIMENTALthe same procedure mentioned above coupled with session of platelet rich plasma before and after transplantation
Interventions
hair transplantation procedure
Eligibility Criteria
You may qualify if:
- Patients with unacceptable visible scarring alopecia.
- Adequate donor area.
- patient free of signs of disease activity evidenced by trichoscopy.
- Patients having inadequate laxity for a strip excision (too tight skin).
- When previous scars of strip surgeries make further strips impossible.
You may not qualify if:
- Inadequate donor area.
- Signs of active disease or infection.
- Patient who is not willing for long sessions for several hours or multiple sessions as needed due to the slowness of the process
- Contraindications for surgical procedure as bleeding tendency.
- Contraindications for PRP as (cardiovascular, autoimmune disorders, hematological disorders and neoplasms).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine
Alexandria, 21521, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of dermatology
Study Record Dates
First Submitted
July 12, 2020
First Posted
July 15, 2020
Study Start
January 5, 2020
Primary Completion
December 5, 2020
Study Completion
December 5, 2020
Last Updated
July 29, 2021
Record last verified: 2021-07